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Abstract
As the number of studies related to the early identifica-
tion of and intervention in the schizophrenia prodrome
continues to grow, it becomes increasingly critical to
develop methods to diagnose this new clinical entity with
validity. Furthermore, given the low incidence of
patients and the need for multisite collaboration, diag-
nostic and symptom severity reliability is also crucial.
This article provides further data on these psychometric
parameters for the prodromal assessment instruments
developed by the Prevention through Risk Identification,
Management, and Education (PRIME) prodromal
research team at Yale University: the Structured
Interview for Prodromal Syndromes and the Scale of
Prodromal Symptoms. It also presents data suggesting
that excellent interrater reliability can be established for
diagnosis in a day-and-a-half-long training workshop.
Keywords: Schizophrenia, prodromal, assessment,
early ^identification.
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International interest has grown over the past 15 years in
the prognostic potential of early identification of and inter-
vention in the prodromal and first episode phases of psy-
chotic illness. As enthusiasm has grown, experts and ethi-
cists have admonished both researchers and clinicians to
proceed with caution and with open dialogue concerning
the preliminary nature of the evidence base. Most needed
is rigorous scientific research, and one of the most critical
elements of this research is the capacity to characterize
and operationally define the concept of the "prodrome to
schizophrenic psychosis" as well as the transition from
"prodromal illness" to the onset of psychosis.
Yung et al. (1996, 1998) pioneered this work by out-
lining three prodromal syndromes that prospectively iden-
tified people who were at high risk for developing schizo-
phrenia in the near future. The three syndromes were
described as (1) frankly psychotic positive symptoms that
appeared too brief and too intermittent to constitute a fully
psychotic syndrome, (2) attenuated positive symptoms,
and (3) functional decline in the presence of genetic risk.
The PRIME prodromal research team at Yale University
has developed two instruments to rate and track these phe-
nomena cross-sectionally and over time (see figure 1 for a
description of the organization of these instruments and a
guide to the acronyms that are used to facilitate communi-
cation). These instruments are the Structured Interview for
Prodromal Syndromes (SIPS) (McGlashan et al. 2001;
Miller et al. 2002; Rosen et al. 2002) and the Scale of Pro-
dromal Symptoms (SOPS) (Miller et al. 1999; McGlashan
et al. 2001; Hawkins et al., in press). The SIPS is a struc-
tured diagnostic interview used to diagnose the three pro-
dromal syndromes and may be thought of as analogous to
the Structured Clinical Interview for DSM-IV (SCID) or
other structured diagnostic interviews. The SIPS includes
the SOPS, the Schizotypal Personality Disorder Checklist
(APA 1994), a family history questionnaire (Andreasen et
al. 1977), and a well-anchored version of the Global
Assessment of Functioning scale (GAF; Hall 1995). The
SIPS also includes operational definitions of the three pro-
dromal syndromes (the Criteria of Prodromal Syndromes
[COPS]) and an operational definition of psychosis onset
(Presence of Psychotic Syndrome [POPS]). As part of the
SIPS, the COPS and the POPS are applied to the informa-
tion from the positive symptoms of the SOPS, the Schizo-
typal Personality Disorder Checklist, and the family his-
tory questionnaire to diagnose a prodromal syndrome or
the presence of psychosis. The SOPS is a 19-item scale
designed to measure the severity of prodromal symptoms
Send reprint requests to Dr. T. Miller, Yale Psychiatric Research, P.O.
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Figure 1. Organization of the SIPS and the SOPS and listing of associated acronyms
Structured Interview for Prodromal Syndromes
(SIPS)
Measures
Scale of Prodromal Symptoms (SOPS) ^ ^ — ^ — _
Schlzotypal Personality Disorder Checklist {DSM-IV)
Family history questionnaire
Global Assessment of Functioning scale (GAF)
Criteria
Presence of Psychotic Syndrome (POPS)
Criteria of Prodromal Syndromes (COPS)
Brief Intermittent Psychotic Symptom syndrome (BIPS)
Attenuated Positive Symptom syndrome (APS)
Genetic Risk and Deterioration syndrome (GRD)
Scale of Prodromal Symptoms
(SOPS)
y Positive Symptoms
Unusual Thought Content/Delusional Ideas
Suspictousness/Persecutory Ideas
Grandiosity
Perceptual Abnormalities/Hallucinations
Disorganized Communication
Negative Symptoms
Social Anhedonia
AvolWon
Expression of Emotion
Experience of Emotions and Self
Ideational Richness
Occupational Functioning
Disorganization Symptoms
Odd Behavior and Appearance
Bizarre Thinking
Trouble With Focus and Attention
Personal Hygiene
General Symptoms
Sleep Disturbance
Dysphoric Mood
Motor Disturbances
Impaired Tolerance to Normal Stress
and changes over time. It may be conceptualized as analo-
gous to the Positive and Negative Syndrome Scale, the
Brief Psychiatric Rating Scale, and other established
severity rating scales for patients who are fully psychotic.
The SOPS contains four subscales for Positive, Negative,
Disorganization, and General Symptoms constructs. There
are five Positive, six Negative, four Disorganization, and
four General Symptoms items. The Negative, Disorgani-
zation, and General Symptoms rated on the SOPS are not
currently part of making prodromal diagnoses according to
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the COPS but are useful in describing the severity of the
diagnosis once established. Information regarding the
SIPS and the SOPS is available from the authors.
The COPS are listed in table 1. They have been modi-
fied from the original criteria developed by Yung et al. in
hopes of improving predictive validity by focusing more
narrowly on patients at imminent risk. Table 1 also pro-
vides a comparison between the COPS and the criteria
developed by Yung et al. as currently operationalized in
their instrument, the Comprehensive Assessment of At
Risk Mental States (CAARMS).
Clinical descriptions of the three prodromal syn-
dromes as defined by the COPS and diagnosed by the
SIPS are available in a number of previously published
manuscripts (McGlashan et al. 2001; Rosen et al. 2002;
Woods and McGlashan, in press). In brief, however, we
also include descriptions of the three prodromal syn-
dromes here. The Brief Intermittent Psychotic Symptom
syndrome (BIPS) is defined by the experience of frankly
psychotic symptoms that do not meet POPS criteria, have
reached a psychotic level of intensity only within the past
3 months, and occur at least several minutes per day at a
frequency of at least once per month. Thus, clinically,
people meeting the BIPS criteria would appear to be expe-
riencing frankly psychotic symptoms of recent onset that
are present infrequently and for short periods of time. The
Genetic Risk and Deterioration syndrome (GRD) is
defined by having a genetic risk, in the form of a first
degree relative with any psychotic disorder, or personally
meeting the DSM-IV criteria for schizotypal personality
Table 1. Comparison of COPS for prodromal patients with CAARMS1
Prodromal
criteria CAARMS COPS
Brief Intermittent
Psychotic
Symptom
syndrome
Attenuated
Positive
Symptom
syndrome
Genetic Risk and
Deterioration syndrome
Severity score in the psychotic range on 1 or more of
3 CAARMS positive items
AND
When duration more than 1 hr per occasion,
frequency less than 3 times per week
When duration less than 1 hr per occasion,
frequency less than daily
AND
Episode duration less than 1 wk
AND
Symptoms present in last yr and for less than 5 yrs
Severity score in the prodromal range on 1 or more
of 3 CAARMS positive items
AND
When episode at least 1 wk long and duration less
than 1 hr per occasion, frequency more than
twice per wk
OR
Frequency once per month and duration less than
1 hr per occasion and more than 2 occasions
AND
Symptoms present in last yr
and for less than 5 yrs
First degree relative with history of any psychotic
disorder
OR
Schizotypal personality disorder in identified
patient or relative
AND
GAF drop of 30% from premorbid level,
sustained for 1 mo
One or more of the 5 SOPS
positive items in the psychotic
range (rating of 6)
AND
Symptoms beginning in the
past 3 mos
AND
Symptoms occurring currently
at least several minutes per
day at least once per mo
One or more of the 5 SOPS
positive items scoring in the
prodromal range (rating of 3-5)
AND
Symptoms beginning within the
past yr or increasing 1 or more
points within the past yr
AND
Symptoms occurring at least
once per wk for last mo
First degree relative with history
of any psychotic disorder
OR
Criteria for schizotypal personality
disorder met in patient
AND
GAF drop of at least 30%
over the last mo vs 1 yr ago
Note.—CAARMS - Comprehensive Assessment of At Risk Mental States; COPS - Criteria for Prodromal Syndrome; GAF - Global
Assessment of Functioning; SIPS » Structured Interview for Prodromal Syndromes.
1
 Yung et al. criteria from CAARMS version distributed May 2002. COPS criteria from SIPS version 4.0 distributed June 2003.
705Downloaded from https://academic.oup.com/schizophreniabulletin/article-abstract/29/4/703/1887836by University of North Carolina at Chapel Hill user
on 10 April 2018
Schizophrenia Bulletin, Vol. 29, No. 4, 2003 T.J. Miller etal.
disorder, as well as having a significant drop in function-
ing as defined by a GAF drop of 30 percent or more over
the past year. This syndrome was included in part to cap-
ture individuals who may be experiencing a prodromal
phase that is predominantly characterized by negative
symptoms, which we expect will be reflected in the signif-
icant drop in functioning as measured by the GAF.
The final syndrome, and in the PRIME samples by far
the most frequent of the three, is the Attenuated Positive
Symptom syndrome (APS). This syndrome is character-
ized by the development or worsening within the past year
of mild or attenuated psychotic symptoms that have not
yet reached a psychotic level of intensity and have been
present at least once per week in the past month. The char-
acteristics of mild or attenuated positive symptoms are
familiar to most clinicians but have generally not been the
focus of sustained investigative attention until recent
years. These patients report experiencing the precursors to
delusions, hallucinations, and thought disorder in the form
of unusual thought content, perceptual abnormalities, and
disorganized speech. Unusual thought content in the atten-
uated realm can be of a paranoid, grandiose, or other
nature and may range from mild to severe but not to psy-
chotic. Clinical examples of this type of symptom include
patient reports of considering the possibility, but clearly
not believing, that others might be able to read their
minds, that they might be able to read others' minds, or
that they might be able to predict or determine the future
from dreams.
One of the key determinants of a symptom being con-
sidered attenuated and not at a fully psychotic level of
intensity is the lack of conviction regarding the externally
generated, "real" nature of the symptom as well as the
maintenance of insight regarding the sense that the experi-
ence is, in fact, a symptom. For example, one high school
student who was experiencing suspiciousness reported
having the feeling that the entire sophomore class in his
school was singling him out and watching him. He also
reported realizing that this was not possible as soon as he
caught the eye of one of his fellow students. Another
young woman reported that even though she lived on the
third floor of an apartment building in a city and knew that
it was not possible for anyone to see directly into her win-
dow, she would sometimes feel that people were watching
her and would sometimes not get undressed at night One
young man who reported grandiose unusual thought con-
tent reported that he had a "weird" feeling that if his
coworkers brushed past him, they would have a better day.
He was quick to counter, however, that he knew that this
was not possible.
Perceptual abnormalities in the attenuated realm can
equally be experienced at a mild to a severe but not at a
psychotic level of intensity. Patients experiencing such
symptoms can report hearing odd noises, such as banging
or clicking or ringing; dogs barking when there is no ani-
mal present; or their name being called when no one has
called them. More severe but still attenuated symptoms
have been described as hearing sounds or voices that seem
far away or mumbled. People also report experiencing
vague perceptual changes such as seeing colors differently,
seeing flashes of light, or seeing geometric shapes. People
have also frequently reported seeing shadows out of the
corner of their eyes or vague ghostlike figures.
Finally, because thought disorder is a subjective expe-
rience that is difficult for the observer to assess, the SIPS
measures this experience through disorganized speech.
Clinically, we look for people who over time have become
circumstantial or tangential in their speech, who are using
odd words or unusual phrases, or who otherwise are begin-
ning to have difficulty getting the point across.
As captured by the three syndromes, the prodrome for
schizophrenic psychosis is conceived as a period of esca-
lating severity of symptoms or functional decline that lies
between the end of the relatively asymptomatic premorbid
phase and the beginning of the frankly psychotic phase of
schizophrenic psychosis (Woods et al. 200\b). The pro-
drome has some similarity on a conceptual basis to "spec-
trum" and other schizophrenia-related constructs but is
sharply distinguished from them. The distinguishing fea-
tures primarily relate to course and trajectory of illness.
The prodrome construct is like schizotypy and schizotaxia
in that symptoms are milder than in frank schizophrenia
but differs from them in that symptoms are of relatively
recent origin and escalating in severity rather than being
stable and enduring. The prodrome construct is similar to
the concept of "children at risk" in sharing heightened risk
for future progression to schizophrenia but differs in
requiring that the state be symptomatic, in not requiring
that family history of schizophrenia be present, and in con-
noting greater imminence of risk. The prodrome construct
should also be compared and contrasted with DSM-IV
conceptualizations of fully psychotic disorders that have
not been present long enough to meet criteria for schizo-
phrenia or schizoaffective disorder. These DSM-IV con-
cepts are psychotic disorder not otherwise specified
(NOS), brief psychotic disorder, and schizophreniform
disorder. These DSM-IV concepts do not overlap with the
APS or GRD prodromal syndromes. DSM-IV schizo-
phreniform disorder mostly maps to definitions of full psy-
chosis as operationalized either by the SIPS or by the
CAARMS. However, as shown in figure 2, some patients
who are late in the course of the BIPS prodromal syn-
drome as defined by the SIPS could simultaneously meet
criteria for early DSM-IV schizophreniform disorder. For
this overlap to occur, the brief intermittent psychotic
symptoms would have to have been present between 1 and
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Figure 2. Relationship between duration of fully psychotic symptoms and diagnostic criteria for psy-
chotic disorder and brief psychotic syndromes across 3 diagnostic systems
Duration
SIPS
DSU-fV
CAARMS
Days W i n Mos
SIP5J wrfi^iyhntfihs psychosis
• an average of 4 days par wfc for a mo
OR
• i cuy u symptoms svnousiy utsofynimng<v dangerous
SIPSBIPS
< an average of 4 days per wk, < 3 mos
not seriously disorganizing of dangerous
Brief psychotic dtorder
• 1 day but < 1 mo
Psychotic Disorder NOS
• 1 day, not yat 1 mo
CAARMS BLIPS
< 1 w k
Schizophrenlform dtorder
• 1 mo but < 6 mos
Schizophrenia
Schteoaffectlve disorder
> 6 mos. Including prodrome
CAARMS Psychosis
> 1 wk
Note.—BIPS - Brief Intermittent Psychotic Symptom syndrome; BLIPS = Brief, Limited Intermittent Psychotic Symptom group;
CAARMS = Comprehensive Assessment of At Risk Mental States; NOS = not otherwise specified; SIPS - Structured Interview for
Prodromal Syndromes.
3 months and also meet DSM-FV schizophreniform disor-
der criteria of being present "a significant portion of the
time." Also as shown in figure 2, patients whose fully psy-
chotic experience is of sufficiently short duration to meet
DSM-IV criteria for psychotic disorder NOS or brief psy-
chotic disorder could potentially meet either BIPS prodro-
mal criteria or full psychosis criteria either using the SIPS
or the CAARMS. Whether such patients meet prodromal
or psychosis criteria depends on frequency of occurrence
or severity for the SIPS and on duration for the CAARMS.
Studies of the prodromal phase to first onset depend
on the ability to reliably and validly diagnose patients in
this phase with standardized criteria. Progress also
depends on the ability to track symptomatic changes over
time and to define operationally the point of conversion
from "prepsychotic" to psychotic levels of symptom inten-
sity. Because psychosis emerges in a dimensional fashion,
the specific "point" of conversion from nonpsychosis to
psychosis has never been defined. Any definition is, to
some extent, arbitrary. Nevertheless, for valid research to
proceed, it is necessary for the field to develop a definition
that can be operationalized and applied reliably. The crite-
ria for onset of frank psychosis used by our group are the
POPS criteria, part of the SIPS interview (figure 1). The
POPS requires that one or more of the positive items from
the SOPS be scored at a psychotic level of intensity and
also describes psychotic symptom frequency and duration
criteria. Figure 2 presents the frequency and duration cri-
teria from the POPS along with a comparison to the
CAARMS onset of psychosis criteria used by Yung et al.
The PRIME Research Clinic at Yale University has
focused on the early identification of and intervention in
psychotic illness. Patients are referred to the PRIME
Clinic as the result of a variety of community education
efforts targeting primarily the psychiatric, medical, and
educational systems. Patients who telephone the PRIME
Clinic are invited for interview if they meet the following
telephone-screening criteria: (1) between the ages of 12
and 45, (2) reporting one or more symptoms that could be
prodromal, and (3) not reporting an established diagnosis
of psychotic disorder or other Axis I or Axis II disorder
that clearly accounts for the possibly "prodromal" symp-
toms.
The PRIME Clinic has been examining the predictive
validity of the SIPS through an ongoing followup study.
Initial predictive validity results demonstrated that of 13
patients diagnosed with a prodromal syndrome at base-
line, 6 (46%) had developed schizophrenic psychosis by 6
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months and 7 (54%) by 12 months (Miller et al. 2002). In
addition, none of the initially nonprodromal patients
developed schizophrenic psychosis by 12 months. Further
updated results from this ongoing study are presented in
this article. Five new subjects have been added, and the
followup interval for most of the cohort has been extended
to 2 years.
Initial interrater reliability data on the SIPS diagnosis
of prodromal syndrome have also been reported (Miller
2002). In our reliability study, 7 subjects were diagnosed
prodromal and 11 were diagnosed as nonprodromal
according to the SIPS. One to three raters per subject in
addition to the interviewer made SIPS diagnoses indepen-
dently from those of the interviewer and other raters by
viewing videotapes of the interviews. The agreement
among raters was 93 percent for the judgment of whether
the subjects were prodromal or nonprodromal (kappa =
0.81, 95% confidence interval = 0.55-0.93). This study
demonstrates that the interrater reliability was excellent
for diagnosis. We have completed a new study examining
interrater reliability among raters for the individual items
on the SOPS. Results will be described in this article.
Investigators in the field of prodromal research must
learn how to identify what, in essence, is a new clinical
entity. This, in turn, requires rater-training workshops built
around the structured diagnostic interview. We know that
diagnostic measures and operational criteria for diagnostic
classification improve the reliability of diagnosis (Feigh-
ner et al. 1972; Luria and Berry 1979; Andreasen et al.
1982; Williams et al. 1992; Ventura et al. 1998). We also
know that standardized rater-training programs have been
shown to teach clinicians and researchers with varying
levels of clinical experience to use these structured inter-
views reliably (Flemenbaum and Zimmerman 1973; Luria
and Berry 1980; Ventura et al. 1993; Gutkind et al. 2001).
The PRIME Clinic has created such a training program
and conducted six workshops to date. We will describe this
training program and the participants' levels of reliability
before and after the workshop.
In this article, we will first update the predictive valid-
ity study. Second, we will describe the training program
that we developed for SIPS interviewers and its results in
improving diagnostic reliability conducted at six sites.
Finally, we will report on the reliability study of the indi-
vidual SOPS items.
Methods
Predictive Validity Study
Subjects. Patients were drawn from a total of 123
consecutive symptomatic, treatment-seeking individuals
who were referred to the PRIME Clinic for a suspected
prodromal syndrome, gave written informed consent, and
were given the SIPS from January 23, 1998, through
September 1, 2002. Of these patients, 55 were ineligible
for the predictive validity study. Of these 55 ineligible
patients, 41 had entered clinical trials (all 41 had been
diagnosed as prodromal at baseline), 12 met POPS criteria
for psychosis, and 2 were missing baseline data on pro-
dromal status. The remaining 68 were eligible for the pre-
dictive validity study; however, thus far only 34 (50%)
have participated.
The mean age of the 34 followup subjects was 17.9
years (SD = 5.8), and 23 (68%) were male. Of these 34, 14
met the criteria for the prodromal syndrome at baseline,
and 20 did not meet the criteria for either psychosis or pro-
dromal syndrome. Of the 34 nonparticipants in the validity
study, 12 are waiting to be scheduled, 12 could not be
located, 9 refused to participate usually because they felt
the time commitment to be burdensome, and 1 was
deceased The mean age for these 34 nonparticipants was
21.8 years (SD = 12.0); 22 (65%) were male, and 14 had
prodromal syndromes.
Procedures. The SIPS was part of a face-to-face
interview that was conducted at baseline and repeated
over evaluation periods of 6, 12, 18, and 24 months. In
four cases, followup interviews were conducted over the
telephone. Patients who were diagnosed at baseline as
prodromal were considered still prodromal unless they
had developed psychosis or had remitted (defined as the
absence of any positive symptom item in the SOPS with a
score in the prodromal range). Interviewers were all "cer-
tified" SIPS raters. To be certified, each interviewer must
have previously participated in sessions with at least five
symptomatic prodromal patients where one of the SIPS
developers was the primary rater and must be judged by
one of the SIPS developers as competent to administer the
SIPS independently (Miller et al. 2002).
Rater-Training Study
Procedures. A standard one-and-a-half-day training
program to teach participants to use the SIPS was devel-
oped at the PRIME Clinic by the developers of the mea-
sures. The program consists of five phases. During the ori-
entation phase, the participants are provided with
looseleaf notebooks that contain copies of the measures,
articles that describe the measures, and copies of the
slides from an introductory lecture and an advanced lec-
ture that addresses specific rating issues. The notebooks
also include the transcripts from four different videotapes,
each accompanied by its own copy of the SIPS.
On the morning of the first day, the trainees are given
an introductory lecture that describes the measures in
detail. This portion of the training is intended to familiar-
ize the participants with the measures enough that they
are oriented to the general goals, format, and characteris-
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tics of the instrument. In addition, the lecture involves a
discussion that includes clinical examples of the three
types of prodromal syndromes denned by the SIPS that is
similar to the one presented in this article. Finally, rele-
vant preliminary psychometric studies are briefly pre-
sented and reviewed.
The trainees are then shown and asked to rate two
different videotapes: one of a patient with prodromal
symptoms and one of a patient who does not meet prodro-
mal criteria according to the SIPS. The trainees are blind
to the diagnosis of each patient as established by the
trainer. The videotapes are discussed at length in an item-
by-item format during the afternoon of the first day.
On the morning of the second day, the trainees are
given a lecture that highlights specific rating issues and
reviews and summarizes the issues discussed the previous
day. Some of the most salient points that are discussed in
this lecture are presented here. First, the concept of "delu-
sional conviction," which is critical to determining the
difference between a severe but not psychotic rating ver-
sus a severe and psychotic rating, is explained.
"Delusional conviction" is considered to be the experi-
ence of believing that an experience is either "real" or
external to oneself without any doubt, at least momentar-
ily. Patients who experience conviction report that they
believe that, for example, the voice that they are hearing
is not being generated by their own brain but rather exists
independently and externally. Individuals who are not
experiencing delusional conviction offer other explana-
tions for their experience. One common comment that is
given to explain a symptom is that, because they believe
that the experience cannot be real, they claim their mind
must be "playing tricks" on them. The raters are
instructed, when using the interview, to query the patients
as to how they account for the experience, whether they
believe that it is real or "just in their head." In the case of
voices, to establish the experience of an hallucination as
differentiated from a thought, interviewers are instructed
to ask such questions as whether the patient can hear the
voice/sound with his or her ears, whether someone else
may be able to hear it, and whether the voice/sound is
heard "out loud" as clearly as the interviewer's voice is
experienced.
The above discussion helps to differentiate between a
severe but not psychotic symptom and a severe and psy-
chotic symptom. We also address the distinction between
a moderately severe symptom and a severe but not psy-
chotic symptom. We point out that the severe but not psy-
chotic rating is reserved for patients who are right on the
edge of believing that their experience is real or external
but who are able to acknowledge that they have some
doubt or that doubt can be induced by contrary evidence
and others' opinions.
One factor that has proven to be slightly confusing to
raters is how to rate a persecutory versus nonpersecutory
idea of reference. The raters are simply reminded that per-
secutory ideas of reference are rated under Suspiciousness
(scale item P.2) and nonpersecutory ideas of reference are
rated under Unusual Thought Content (scale item P.I).
The raters are reminded of some of the other information
that is provided in the SIPS instructions but is sometimes
overlooked as well as some general issues related to rat-
ing scales. They are reminded that the interview inquires
about the experience of the patient over the lifetime but
that the ratings on the SOPS refer to the patient's experi-
ence over only the past month. Also, they are reminded
that the SIPS and SOPS are designed to be phenomeno-
logical measures. In other words, the rater is not intended
to change any rating based on what he or she believes the
cause of the patient's experience may be. If, however,
each symptom otherwise qualifying for a prodromal diag-
nosis is better explained by another DSM-FV diagnosis,
the patient may not be diagnosed with a prodromal syn-
drome. For this reason, we now recommend that the SIPS
be used in conjunction with another, more general diag-
nostic measure, such as the SCTD. Along similar lines, the
raters are told that ratings are not intended to be made
based solely on information provided by a collateral
source but rather should be based on interviewer observa-
tion and/or patient report. When the collateral and patient
sources of information disagree, we suggest that the col-
lateral informant be present in the interview to confront
the patient with the discordant information.
Raters are also reminded that when in doubt over a
particular rating, they should rate to the extreme, keeping
in mind that the moderate to severe but not psychotic
range is considered to "put" a symptom into the attenu-
ated psychotic range of intensity. Finally, the anchors,
provided to guide raters to choose a particular level of
intensity for any given symptom and to maximize inter-
rater reliability, cannot enumerate every possible sympto-
matic experience, especially because of the heterogeneous
nature of the experiences of patients in the prodromal
phase of psychosis. Thus, raters are encouraged, when in
doubt, to revert to the general descriptors of different
scale points such as mild and moderate.
The events of the first day and the morning of the
second day constitute the training portion of the rater-
training workshops that are reported in this article. At the
end of the training workshop, the trainees are then asked
to view and rate two new videotapes; again, one video-
taped patient has prodromal symptoms and the other does
not meet criteria for a prodromal syndrome according to
the SIPS. This set of second ratings is intended to measure
the effect of the rater-training workshop. Again, the
trainees are blind to the established diagnosis. The
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remainder of the second day is spent answering any fur-
ther questions that arise and any of the items that partici-
pants are interested in discussing further, even though it is
not possible to measure the effect of these further discus-
sions.
Trainer and videotapes. Tandy J. Miller, a licensed
clinical psychologist and one of the original developers
of the SIPS and the SOPS, provided all of the training.
All of the patients who attend interviews at the PRIME
Clinic are invited to have their baseline interviews video-
taped. If they assent, they are asked to sign a consent
form authorizing the principal investor to use the video-
tapes for purposes relevant to this research, including
training. When the patient is a minor, the parent or
guardian is asked to give consent and the minor to give
assent. The same set of four videotapes, in the same
order, was used in each of the rater-training workshops.
The specific videotapes were chosen based solely on an
attempt to maximize the sound and recording quality of
the taped interviews. The tapes are judged by other certi-
fied raters to be of a consistent level of difficulty in terms
of diagnostic determination.
Participants. Rater-training workshops were con-
ducted six different times at five sites with 35 raters. The
sites were the Maine Medical Center, Portland, ME
(MMC: 7 raters); the University of California San Diego,
San Diego, CA (UCSD: 5 raters); the University of
California Los Angeles, Los Angeles, CA (UCLA: 7
raters); the Institute of Living, Hartford, CT (IOL: 8
raters), the Maine Medical Center, Portland, ME (Maine:
2 raters not trained with the first group); and the
University of North Carolina, Chapel Hill, NC (UNC: 6
raters). The participants in the rater-training workshops
were all native, English-speaking mental health profes-
sionals. The group included licensed psychologists, psy-
chiatrists, master's level health care professionals, nurses,
and research assistants.
"Gold-standard" ratings and analysis. The four
training videos that are accompanied by "gold-standard"
ratings, as determined by Dr. Miller, are used for comput-
ing pretraining videos 1 and 2 and posttraining videos 3
and 4 interrater reliability and in providing the trainees
with feedback. We use the kappa statistic to compare
trainee agreement with the gold-standard diagnosis on
presence or absence of a prodromal syndrome (Cohen
1960). Definitions of clinical or practical significance for
kappa and r i c c have been proposed (<0.40, poor;
0.40-0.59, fair; 0.60-0.74, good; <0.75, excellent)
Cicchetti and Sparrow 1981).
SOPS Interrater Reliability Study
Subjects. SOPS interrater reliability was examined
in 14 consecutive baseline interviews of subjects who
were evaluated as being prodromal for psychosis when
two or more raters were present between March 3, 2000,
and March 21, 2001. These subjects ranged in age from
12 to 26, with a mean age of 16.5. There were seven
females and seven males. Six were Caucasian, three were
of African descent, four were of Hispanic descent, and
one was of Asian descent.
Raters. The raters for this reliability study were one
licensed, clinical psychologist (TJ.M.) and two psychol-
ogy postdoctoral fellows (including J.L.R.). The inter-
viewer was one of the raters in each case. The interviewer
asked about the subject's symptoms as per the SOPS pro-
cedures. The interviewer was one of the SOPS developers
(T.J.M.) or a certified interviewer (J.R., L.S.). All raters
were trained in the use of the SOPS through an appren-
ticeship model, as described above.
Procedures. Ratings for this reliability study were
made in person by two to three raters who were present
during the session. The number of raters varied from two
to three, depending on the number of people available to
be present at a particular session. Ratings for du's reliabil-
ity study were made and recorded independently and not
discussed among raters.
Analysis. Intraclass correlations were generated
using a computer program that permits calculation of ricc
when the number of raters is unequal across subjects
(Cicchetti and Showalter 1988).
Results
Predictive Validity. In the validity study, 13 of the 14
initially prodromal patients met die prodromal syndrome
defined by attenuated positive symptoms at baseline, and
1 met the prodromal syndrome defined by brief intermit-
tent psychotic symptoms. No patient met GRD criteria in
this sample. Figure 3 shows that 6 of the 14 (positive pre-
dictive value [PPV] = 43%) developed schizophrenic psy-
chosis by 6 months and that the PPV was 50 percent at 12
months. Sensitivity and specificity were 100 percent and
71 percent, respectively, at 6 months and 100 percent and
74 percent at 12 months. At 18 months the PPV was 62
percent (8 of 13) and at 24 months 67 percent (8 of 12).
Sensitivity and specificity were 100 percent and 74 per-
cent, respectively, at 18 months and 100 percent and 73
percent at 24 months. Of the 7 initially prodromal patients
at baseline who did not convert by 12 months, 5 of these
remained prodromal, 1 remitted, and 1 developed a new
DSM-FV disorder (major depression). The difference in
conversion rates between initially prodromal and initially
nonprodromal subjects was highly significant at each time
point using Fisher's exact test (p < 0.005 at 6 and 24
months, p < 0.001 at 12 and 18 months). Of the 20 ini-
tially nonprodromal patients, none developed schizo-
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SIPS+
SIPS-
(18%)
(0%)
(24%)
20 (59%)
Incidence
SensHMty
Specificity
Positive predtetrva value
Prediction ratio
18%
100%
71%
43%
Inf.
Figure 3. Conversion rates to schizophrenic psychosis and diagnostic efficiency measures at 6,12,
18, and 24 mos among 34 subjects who underwent baseline SIPS interview
SIPS interview
6-mo 6-mo
converter* nonconwrters Total
14 (41%)
20 (59%)
Total 6 (18%) 28 "(82%) 34 (100%)
12-mo 12-mo
converters nonconvwrters Total
SIPS+ J7 (21%) [7 (21%) |14 (41%)
SIPS- 0 (6%) 20 (59%) 20 (59%)
Total 7 (21%) 27 (79%) 34 (100%)
18-mo 18-mo
converters nonconverters Total -
SIPS+ [8 (30%) [5 (19%) |13 (48%)
SIPS- 0 (0%) 14 (52%) 14 (52%)
Total 8 (30%) 19 (70%) 27 (100%)
24-mo 24-fno
converters nonconvertsrs Total
SIPS+ [§ (35%) B (17%) |12 (52%)
SIPS- 6 (0%) 11 (48%) 11 (48%)
Total 8 (35%) 15 (65%) 23 (100%)
Incidence
Sensitivity
Specificity
Positive predictive value
Prediction ratio
21%
100%
74%
50%
Inf.
Incidence
Sensitivity
Specificity
Positive predfctfve value
Prediction ratio
30%
100%
74%
62%
Inf.
Incidence
Sensitivity
Specificity
Positive predictive value
Prediction ratio
35%
100%
73%
67%
Inf.
Note.—Inf. = infinite; SIPS = Structured Interview for Prodromal Syndromes.
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Table 2. Agreement between trainees and trainer on SIPS diagnosis before and after a 2-day
rater-training workshop1
Measure
Agreement
With trainer
Session
Before
After
MMC
0.571
0.714
UCSD
0.400
0.800
UCLA
0.429
0.857
Site
IOL
-0.250
1.00
Maine
0.500
1.00
UNC
0.500
0.833
All sites
0.314
0.857
Note.—IOL - Institute of Living; Maine » Maine Medical Center (2 raters in second group); MMC - Maine Medical Center (7 raters In first
group); UCLA - University of California, Los Angeles; UCSD - University of California, San Diego; UNC - University of North Carolina,
Chapel Hill.
1
 Agreement expressed as kappa values (< 0.40, poor; 0.40-0.59, fair; 0.60-0.74, good; 2 0.75, excellent).
phrenic psychosis. Although none of these 20 initially
nonprodromal patients ever met psychosis criteria, two of
them newly met prodromal criteria by 12 months and a
third by 18 months. Two of these three subjects then
entered a clinical trial, so data on further medication-free
followup could not be obtained. The third has not been
followed beyond 12 months so far. Additional evidence
that patients who did not develop schizophrenic psychosis
were correctly diagnosed is that only two (378, 396)
received antipsychotic medication during followup so far,
and in both of these cases the indication was not psy-
chosis.
Rater Training. Table 2 shows diagnostic agreement
before and after training at each site. The data demon-
strate that agreement with the "gold standard" before
training was poor among all 35 trainees as well as poor or
fair at each individual site. Posttraining data, in contrast,
reveal that agreement among all 35 trainees at the six dif-
ferent sites was in the excellent range. In addition, per site
posttraining data demonstrate that agreement among
raters with the "gold standard" in five out of the six sites
was in the excellent range and near the excellent range in
the final site.
SOPS Interrater Reliability. Reliability analyses on the
SOPS severity rating scale revealed that the ricc value was
0.95 for the total score and above 0.75 for all four sub-
scales (Positive, Negative, Disorganized, and General
Symptoms subscales), thus being in the excellent range
for the total score and all subscales. For individual items,
agreement was in the excellent range for 17 out of 19 and
near the excellent range for the other 2 (0.70 and 0.72).
Discussion
The relationship between the initial SIPS diagnosis and
the 24-month followup data supports the predictive valid-
ity of the COPS when used in association with the SIPS.
The overall rate of transition to schizophrenic psychosis at
12 months observed in our small sample (7 of 14, 50%) is
similar to that observed in a larger sample (20 of 49,
40.8%) (Yung et al. 2003). Because the COPS used in our
PRIME Clinic were based on the Yung et al. criteria, the
similarity in predictive validity results suggests that pro-
dromal diagnostic criteria may be applied consistently
across sites.
One methodological consideration in comparing the
current findings with the Yung et al. (2003) findings relates
to differing definitions of the exit point to psychosis in
these two longitudinal studies of the prodrome. The differ-
ences relate to differing symptom measures to determine
whether full psychosis criteria are met, as well as to differ-
ing duration criteria of fully psychotic symptoms. For the
Yung et al. criteria, the symptom measures originally were
based on the BPRS and the Comprehensive Assessment of
Symptoms and History. The symptom measure currently
used is the CAARMS. In our work with the POPS criteria,
the symptom measure has been the SOPS. The duration
criteria differences are shown in figure 2. Inspection of the
POPS criteria and the Yung et al. criteria suggest that they
are likely to be strongly overlapping, but empirical studies
have not been conducted to determine how often the same
patients would meet both sets of criteria for onset of psy-
chosis at the same time.
Another consideration in comparing the current
results with those from Yung et al. (2003) relates to diag-
nostic classification of the nonconverters. In the compari-
son sample, 12 of 29 nonconverters (24.5% of the total
sample of 49) were reported to have no diagnosis at 12-
month followup, and 15 of 29 (30.6%) were reported to
have a nonpsychotic diagnosis. In our study, diagnostic
classification at followup provided for the possibility that
patients could be classified as still meeting prodromal cri-
teria, and 5 of 7 nonconverters met such criteria. These
patients are believed to be still at risk for conversion, and 1
of 5 did convert by 18 months. If these cases are consid-
ered as remaining at risk and thus not yet false positives,
the proportion of "true false positives" at 12 months is
only 2 of 14 (14%).
Other differences in methodological procedures are
evident in table 1. Although the two sets of prodromal cri-
teria in table 1 are generally similar, the COPS in general
are somewhat more restrictive. The CAARMS permits
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patients with relatively stable symptoms over the past 5
years to meet criteria, while for APS the COPS require
patients to be getting worse in the past year. For BIPS, the
COPS require that symptoms have reached the psychotic
range in the past 3 months. For GRD, the CAARMS per-
mits patients with a family history of schizotypal personal-
ity disorder to meet criteria, while the COPS do not. These
differences may explain why BIPS and GRD have been
observed less frequently when using the COPS than when
using the Yung et al. criteria (Miller et al. 2003).
In addition to followup data on patients initially diag-
nosed as prodromal, we report followup data on patients
who were sufficiently symptomatic to be invited to a SIPS
interview but who did not meet prodromal criteria. Other
groups have not yet reported similar data. The findings
suggest that a diagnosis of "not prodromal" on SIPS inter-
view is strongly predictive of not converting to psychosis
by 12 months (20 of 20, 100%). Interestingly, three such
patients did develop prodromal syndromes over time,
however. These findings suggest that patients initially
diagnosed as not prodromal should be urged to return for a
followup evaluation if symptoms worsen.
An important limitation of the present predictive
validity data, in addition to the small sample sizes, is the
relatively low participation rate (50%) that has occurred so
far. If the sample that has not yet participated is discovered
to show a higher or lower conversion rate for the initially
prodromal subjects or a lower conversion rate for the ini-
tially nonprodromal subjects, then the sensitivity, speci-
ficity, and PPV values shown in figure 3 will be altered.
Another limitation is that followup diagnostic assessors
were not blind to the results of the initial assessment. From
the point of view of providing a stringent test of the valid-
ity of the initial assessment, blind followup ratings would
have been preferable. On the other hand, the procedure we
followed made it possible for the followup interviewer to
review the results of the initial assessment and may thus
have been preferable from the viewpoint of exploring the
course of illness in these patients by increasing sensitivity
of detection of psychopathology.
The key to achieving consistent predictive validity is
to maximize diagnostic interrater reliability across raters
and sites. The present significant results from the training
workshop suggest that it is possible to achieve excellent
diagnostic interrater reliability with a minimum of train-
ing. These results demonstrate that diagnostic agreement
across sites is possible when using the SIPS, suggesting
that inclusion criteria have the potential to be reliably
applied in multisite studies using the SIPS.
Before training, the raters were preliminarily familiar
with the instrument and had been oriented to it. The
before-and-after training comparison thus represents a fan-
test of the need for training on the measure beyond a basic
orientation program. The poor reliability observed before
training suggests that training is needed before raters
should use the SIPS to make prodromal diagnoses. This
may not be true for every rater and may depend on each
rater's level of clinical experience, familiarity with other
structured interviews, and familiarity and experience with
prodromal patients.
Caveats about the training data are important to
emphasize. The training to reliability data presented here
are preliminary and are based on ratings of only two
videotapes per rater. Further reliability studies would be of
value. The training program offered at the training sites
evaluated the reliability of trainees to make a diagnostic
rating but not their ability to elicit relevant information in
an actual interview setting. Assessment of interview relia-
bility rather than rating reliability would require subjects
to undergo two or more independent interviews with dif-
ferent interviewers within a short span of time. Although
this procedure would impose a substantial burden on the
subjects, a study investigating interviewer reliability for
the prodromal diagnosis should probably be conducted.
Lastly, our training data are limited in that they include
only native English-speaking participants. The SIPS and
the SOPS have been translated into 14 different languages
for use in studies around the world, necessitating the cre-
ation of workshops for participants who do not have Eng-
lish as a first language.
Finally, the results from the SOPS interrater reliability
study demonstrate that certified raters are able to achieve
excellent interrater reliability on the total score, excellent
reliability on all four SOPS subscales, and excellent or
near-excellent reliability on all of the 19 individual items.
These data suggest that the SOPS may be useful as a mea-
sure to describe severity of illness among prodromal
patients, both at baseline and over time in studies with lon-
gitudinal designs. It is useful to note, however, that the
training workshop described earlier has been geared
toward agreement on prodromal diagnosis for the purposes
of enrollment into studies, and not on agreement about the
severity of patient's prodromal symptoms. Although we
have demonstrated that the interrater reliability within our
PRIME site in New Haven is excellent for that aim, it is
likely that additional training beyond a day-and-a-half will
be necessary to establish reliability for severity of illness.
The followup studies reviewed and the data from our
clinic represent converging lines of evidence suggesting
that the prodromal diagnosis is a viable concept that can
be operationally defined with validity from a prospective
viewpoint. Being able to identify the prodrome with relia-
bility and validity strongly supports studies into the nat-
ural history, pathophysiology, and possible treatment of
this clinical, at-risk syndrome. On a cautionary note, how-
ever, it is important to emphasize that the reliability and
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validity found in these studies are in part a function of the
enriched base rate of conversion in the PRIME Clinic
samples. In our predictive validity sample the incidence of
new cases of schizophrenic psychosis without regard to
the SIPS results was 21 percent per year in the first year,
approximately 200 times the annual population incidence
rate for this age range (Woods et al. 2001a). It is important
to emphasize that the results we have observed may not
generalize to samples with less enriched base rates.
The imperfect predictive validity, on the other hand,
signals the need to find additional markers of risk to mini-
mize the number of false positive identifications. There
may well be multiple psychopathological pathways into
the first psychotic episode, and the need to map additional
pathways needs to be borne in mind, as does variability in
content and sequence of symptoms. We are still in a very
early stage of measuring this phase of illness from a psy-
chopathological point of view. Larger samples are needed
to explore alternative diagnostic cutoff values on positive
prodromal symptoms and to explore the possible diagnos-
tic value of other symptomatology, including negative
symptoms and self-experienced cognitive decline. In addi-
tion to clinically detected symptoms, many other factors
may signal dysequilibrium as a harbinger of decline.
These factors should be included in future studies to aug-
ment information obtained from clinical interviews. Meth-
ods that could be able to detect such other factors include
stress evaluations, neuropsychological testing, neurologi-
cal soft signs or minor physical anomalies, structural and
functional imaging, electrophysiology, and genotyping.
These studies optimally should be conducted before stan-
dards to care evolve so that medication-free longitudinal
followup is ethically acceptable.
In addition to the SIPS and SOPS, whose psychometric
properties are described in this article, other assessment
instruments are available and in use for the prodrome. These
include the CAARMS (Yung et al. 2003), which has been
discussed earlier, and the Bonn Scale for the Assessment of
Basic Symptoms (KlosterkOtter et al. 2001). Future research
on the prodrome, therefore, should also include studies that
apply more than one instrument to the same sample. In this
way, data concerning overlap and concordant validity can be
generated. These studies can enhance the generalizability of
the results obtained wim any single measure.
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